Dyslipidemia Drugs: Statins Flashcards

1
Q

What is the site of free fatty acid and cholesterol absorption

A

lumen of small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cholesterol esters are packaged into the interior of chylomicrons in

A

intestinal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_______ make up most of the chylomicron

A

triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chylomicrons contain

A

surface apolipoproteins A, B, C, and E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chylomicrons deliver triglycerides from the

A

intestine to peripheral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Triglycerides in chylomicrons and VLDLs are hydrolyzed by

A

LPL, releasing free fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Free fatty acids can be

A
  1. used for energy by heart and skeletal muscle

2. converted back into triglycerides and stored in adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chylomicron remnants return to the

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The LDL receptor binds to

A

ApoE and transports chylomicron remnant into liver via endocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cholesterol from chylomicron remnants are used by

A

the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HMG CoA reductase synthesizes

A

cholesterol in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The first intermediate in cholesterol synthesis is

A

mevalonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_______ make up most (~60%) of the VLDL

A

triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cholesterol esters are packaged into the interior of VLDLs in

A

hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Apolipoprotein B100 is found on

A

“bad cholesterol” (LDL and VLDL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

VLDLs deliver triglycerides from the liver to

A

peripheral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Low density lipoprotein (LDL) is formed as

A

VLDLs lose triglycerides via LPL and hepatic lipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LDLs contain a core of

A

cholesterol esters

19
Q

LDLs deliver cholesterol to

A

peripheral tissues expressing LDL receptors

20
Q

LDL receptor binds

A

ApoB and transports LDL particle into liver via endocytosis

21
Q

Nascent HDL is secreted by the

A

liver and intestine

22
Q

HDL extracts cholesterol from

A

peripheral tissues

23
Q

Lecithin:cholesterol acyltransferase (LCAT)

A

converts free cholesterol into cholesterol esters for transport by HDL

24
Q

Mature HDL particle contains

A

LCAT-generated cholesterol esters

25
Q

HDL transfers

A

cholesterol esters to LDLs and VLDLs to be transported back to the liver

26
Q

HDL delivers cholesterol esters

A

directly to the liver via scavenger 1 receptor

27
Q

Statins include

A
  1. simvastatin
  2. atorvastatin
  3. rosuvastatin
28
Q

Statins inhibit

A

HMG CoA reductase

29
Q

Statins cause

A

increased LDL receptor expression on hepatocytes, clearing LDLs from circulation

30
Q

Statins are the most effective drugs for lowering

A

LDLs (30-60%)

31
Q

Statins can

A
  1. Decrease LDL
  2. Decrease Triglycerides
  3. Increase HDL
32
Q

Statins have a mild effect on

A
  1. triglycerides

2. HDL

33
Q

Hypercholesterolemia (LDL) is treated with

A

lifestyle modification and statins (first-line agent)

34
Q

Statins improve

A

survival

35
Q

Statins are the most effective lipid lowering drug for preventing

A

future cardiac events

36
Q

Statins are the only lipid-lowering drug consistently proven to

A

reduce risk of atherosclerotic heart disease

37
Q

Statin therapy is initiated in setting of

A

MI and other acute coronary syndromes (ACS)

38
Q

statins reduce risk of cardiovascular events and mortality in

A
  1. high-risk diabetics

2. Peripheral artery disease

39
Q

Statins reduce risk of future vascular events in patients with

A

a history of a TIA or stroke

40
Q

Statins may be

A

teratogenic

41
Q

Statins can cause

A
  1. myopathy weeks to months after starting therapy (muscle weakness/soreness)
  2. elevations in serum CK (myopathy)
42
Q

What effect do statins have on liver function tests

A

mild elevations in liver function tests (LTFs) are common (reversible with discontinuation of statin)

43
Q

All statins except for pravastatin are metabolized by

A

cytochrome p450 (CYP-450) in the liver